19 August 2026 | 5:48PM AEST Equity Research Healius Ltd. (HLS.AX) Threading the needle to cash flow break even; Sell HLS.AX 12m Price Target: A$0.39 Price: A$0.42 Downside: 7.9% The 2H26 performance demonstrated an uptick in EBIT margin for the group reflecting the reduction in headcount undertaken early 1H26. Whilst this demonstrates progress on HLS' initiatives in lifting profitability, we note the ongoing pressure on cashflows largely from lease payments. For FY27, we forecast the business to be breakev ...